Welcome to YLOAN.COM
yloan.com » compensation » Managing Clinical Investigator Compensation
Insurance Currency-Trading Debt-Consolidation Debt-Relief Estate-Plan-Trusts Investing Mortgage-Refinance Real-Estate Real-Estate-FSBO compensation cards strategies fiscal

Managing Clinical Investigator Compensation

Managing Clinical Investigator Compensation


Improve cost-effectiveness of investigator compensation - and ensure compliance.

Establishing transparent and defensible compensation processes for clinical investigators not only saves money - it is absolutely essential in today's restrictive pharma landscape. Regulatory groups, legislative bodies and consumer advocacy groups are applying relentless pressure on commercial relationships with physicians, altering and often limiting industry practices. Now the ripple effect is hitting clinical operations. Some investigations in the area have garnered public attention, with more bound to follow.

Cutting Edge Information projects that within five years the same regulatory scrutiny currently on the commercial side will expand to the clinical side. Companies that do not recognize this inevitable reality and formalize their FMV processes today put themselves at great risk for compromised trial results, an audit, financial damage and regulatory scrutiny. Diligence and constant monitoring will go a long way to preventing careless errors and courting potentially dangerous consequences.


Managing Clinical Investigator Compensation gives your company what it needs to be proactive and prepare for change while avoiding common pitfalls. CEI surveyed more than 50 companies of all types and sizes, across 13 different therapeutic areas, for the most up-to-date compensation rates for clinical investigators. For the most comprehensive analysis, CEI compiled and analyzed data from companies' clinical operations as well as primary investigators.

Use the data benchmarks to:

Control costs

Establish current, market based payments to investigators

Develop regulation-proof calculation and documentation methods

Stay current on the latest FMV regulation concerns and trends

Companies Included in Report

The surveyed companies provided primary information either in the form of survey data or a telephone interview. Cutting Edge Information's analysts use secondary data to supplement the information provided by study participants. Responding companies include five top 20 and 10 Top 50 pharmaceutical companies, as well as biotechnology companies, medical device firms and third-party providers.

Therapeutic Areas Included in Report

Autoimmune

Cardiology and Thrombosis

CNS/Psychology

Dermatology

Endocrinology

Gastroenterology

Hematology

Infectious Diseases

Medical Devices

Musculoskeletal

Oncology

Respiratory

Women's Health

Metrics Included in Report

Managing Clinical Investigator Compensation's three chapters include compensation data collected from clinical investigators as well as pharmaceutical, biotechnology and medical device companies. Data include breakdowns by phase, therapeutic area and experience.

Investigator Compensation: Industry Data

Percentage of time that companies monitor negotiations between CROs and investigators

Percentage of companies that hire CROs to recruit investigators

Percentage of companies that hire CROs to contract investigators

Percentage of time that CROs handle investigator payments

Percentage of companies with a formal process in place for determining investigator compensation

Percentage of companies that allow primary investigators to concurrently lead clinical trials for other companies

Average years of experience required for primary investigators, by phase

Average years of experience required for primary investigators, by company type and by phase

Articles Published and Speeches Delivered

Percentage of companies whose criteria for primary investigators include published articles

Average number of published journal articles required of primary investigators, by phase

Percentage of companies with investigator compensation limits in place

Average number of total site fees by phase

Average number of investigators per site, by phase

For more information kindly visit

http://www.bharatbook.com/detail.asp?id=100598&rt=Managing-Clinical-Investigator-Compensation.html

OR Contact us at

Bharat Book Bureau

207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.


Phone : +91 22 2757 8668 / 2757 9438

Fax : +91 22 2757 9131

E-mail : info@bharatbook.com

Website : www.bharatbook.com
Compensation For Victims Of Negligence How To Get The Best Workers Compensation Attorney In Woodbridge? What Everyone Should Know About Workers Compensation Compensation With Hospital Liability Compensation for Ground Zero Workers BP Oil Spill Claim - How to Get Compensation From BP Oil Spill Incident Searching For Accident Compensation In Manchester? Amega Global – The Compensation Plan Guide To Compensation For Whiplash Fixodent Lawsuits Can End In Compensation For Those Who Have Suffered From Zinc Poisoning If Reglan Caused Your Tardiv Dyskinesia, Then You May Be Able To Receive Compensation Compensation Plans - ' The Breakaway ' Lord Young Finally Admits 'compensation Culture' Is A Perception
print
www.yloan.com guest:  register | login | search IP(3.16.147.87) / Processed in 0.008888 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 102 , 4711, 384,
Managing Clinical Investigator Compensation